Target intelligence / Profile preview

Redox-active copper pool (RCP)

Target
RCP
Molecular classification
Metal ion pool, Intracellular ion, Other
01

Overview

The redox-active copper pool, also known as the labile copper pool, refers to the fraction of intracellular copper ions that are loosely bound to low-molecular-weight ligands and are readily available for biochemical reactions (Tsvetkov et al., Science, 2022). This pool is distinct from copper sequestered within the active sites of metalloproteins and is essential for maintaining cellular homeostasis by providing copper for mitochondrial respiration and antioxidant enzymes (Ge et al., Nature Chemical Biology, 2022). However, an excess of redox-active copper can lead to toxicity through the generation of reactive oxygen species via Fenton-like chemistry or by triggering cuproptosis, a regulated cell death pathway involving the aggregation of lipoylated proteins (Tsvetkov et al., Science, 2022). In many cancers, the redox-active copper pool is expanded to support rapid proliferation, signaling, and angiogenesis, making it a significant therapeutic target (Brady et al., Nature, 2014). Therapeutic strategies include the use of copper chelators like tetrathiomolybdate to deplete the pool and copper ionophores like elesclomol to overload the pool and induce selective cell death in malignant cells (Blockhuys et al., Journal of Trace Elements in Medicine and Biology, 2017). Monitoring this pool is critical in managing copper-related disorders such as Wilson disease and in the development of novel copper-dependent anti-cancer agents.

Other names
Labile copper poolExchangeable copper poolBioavailable copperIntracellular copper poolCu(I)/Cu(II) pool
02

Mechanism of action

Modulation of intracellular copper levels via chelation to deplete copper or ionophore-mediated transport to induce copper-dependent cell death (cuproptosis).

03

Biological functions

Redox signalingMitochondrial respirationEnzyme cofactor homeostasisCell deathAngiogenesisOther
04

Disease associations

CancerNeurodegenerative diseaseInflammationOther
05

Safety considerations

Systemic copper deficiencyAnemiaNeutropeniaNeurotoxicityHepatotoxicityOff-target metal chelation
06

Interacting drugs

Elesclomol

5 more in the full profile.

07

Biomarkers

FDX1 (Ferredoxin 1)LIAS (Lipoic acid synthase)DLAT (Dihydrolipoamide S-acetyltransferase)Serum free copperUrinary copper

Beyond the preview

Go deeper on Redox-active copper pool (RCP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redox-active copper pool (RCP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call